FDA Agent Pro
← All articles FDA Import Detention Liability Explained: Who Pays? how-to

FDA Import Detention Liability Explained: Who Pays?

Table of Contents

Last Updated: October 16, 2026

FDA Import Detention and Liability: The Core Rules

FDA import detention is the process where the U.S.

Regulatory affairs manager reviewing shipping documents and an FDA notice regarding detention liability
Regulatory affairs manager reviewing shipping documents and an FDA notice regarding detention liability

That last point is where most guides go quiet. Detention is not just a delay.

This guide from FDA Agent Pro breaks down who pays, who answers to the FDA, and how to get a shipment moving again.

Here is the short answer: liability follows the importer of record, not the factory overseas. Everything else flows from that rule.

Who Is Liable When FDA Detains an Imported Product?

The importer of record is legally liable when the FDA detains a shipment. That party, not the foreign manufacturer, owns the compliance burden. The FDA treats the importer of record as the responsible party for admissibility.

This surprises a lot of overseas exporters. They assume the FDA will chase the factory. It won't. The FDA deals with the U.S. entity that brought the goods in.

So who actually is the importer of record? It can be:

  • The U.S. owner or buyer of the goods
  • A customs broker acting on the buyer's behalf
  • A U.S. subsidiary of the foreign company

The name on the entry paperwork decides everything.

Liability by Party: Importer of Record, Agent, Carrier, and Foreign Manufacturer

Liability splits across four parties, and each one carries a different share.

Party Legal Liability Financial Exposure
Importer of record Full legal responsibility for admissibility Storage, re-export, destruction, legal fees
U.S. agent No ownership of goods; handles FDA correspondence Limited to service failure claims
Carrier Custody only until release Freight and demurrage charges
Foreign manufacturer None under U.S. entry law Contract penalties, lost future orders

The importer of record answers to the FDA. The U.S. agent answers to the importer. The carrier just holds the boxes. And the foreign manufacturer, despite making the product, has no direct legal duty under U.S. entry rules.

This is the part most people get wrong. They think the factory is on the hook. It isn't, at least not legally.

Watch Out A common mistake is letting a customs broker sign as importer of record without understanding the risk. If that broker is named on the entry, the broker owns the liability, and your goods can sit for weeks while responsibility gets sorted out.

Liability by Product Type: Food, Drugs, Devices, and Cosmetics

Liability rules shift depending on what you ship.

Food imports face the strictest scrutiny.

Drugs carry higher stakes. An unapproved new drug or a mislabeled product can trigger refusal and possible seizure.

Medical devices hinge on registration and listing. An unregistered device or a missing 510(k) is a fast track to detention.

Cosmetics now fall under MoCRA, the Modernization of Cosmetics Regulation Act (the FDA). Facility registration and product listing are required, and a gap there can stop a shipment cold.

Here is the pattern: the more regulated the product, the less room for error. And the liability always sits with the importer of record.

FDA Import Detention Timeline: From Detention to Release or Refusal

Most detentions resolve within 30 days if the importer responds with solid evidence. The clock starts when the FDA issues its notice. Speed matters more than almost anything else, but so does understanding what accrues while the shipment sits.

Here is how the timeline usually runs:

  1. Day 0: The FDA detains the shipment at the port of entry.
  2. Days 1-5: The FDA issues a Notice of Action or Notice of Detention. The notice identifies the specific violation and the evidence required to overcome it.
  3. Days 5-20: The importer gathers evidence and submits a response. This is the window where most of the cost accumulates.
  4. Days 20-30: The FDA reviews the submission and decides.
  5. Day 30+: The FDA releases the goods or refuses admission.

If the FDA refuses admission, the importer has a short window to re-export or destroy the goods.

How Long Can FDA Hold a Shipment?

The FDA can hold a shipment for up to 30 days before it must release or refuse it. That is the standard window under FDA import operations. But the hold can stretch longer if the importer's response is incomplete or late.

Thirty days sounds generous. In practice, it isn't. Every day of storage adds cost, and perishable goods don't wait.

What Costs Accrue While a Shipment Is Detained?

Detention is a liability event, and the meter runs daily. The importer of record typically absorbs:

  • Port storage and terminal fees, charged per container, per day, by the terminal or warehouse holding the goods.
  • Demurrage and detention charges, assessed by the ocean carrier when containers sit beyond free time; these escalate sharply after the free window closes.
  • FDA examination costs, if the agency samples or tests the product, the importer may be billed for the analysis.

A common pattern is that storage and demurrage alone can exceed the value of a low-margin shipment within a few weeks. That is why the response window matters as much as the response itself.

Deadlines by Notice Type

Not every notice carries the same clock. A Notice of Detention typically gives the importer a defined window, often measured in days, not weeks, to submit evidence. A Notice of Action may set a different response period depending on the violation cited. Import alerts under detention without physical examination (DWPE) can trigger automatic detention on every future shipment until the firm is removed from the alert, which changes the timeline from a single-shipment problem to an ongoing operational one.

Key Takeaway The single biggest factor in how long a detention lasts, and how much it costs, is how fast you respond with complete evidence. A clean, complete response on day five beats a partial one on day twenty every time.

FDA Detention Notice Response Letter: What to Include

A strong FDA detention notice response letter answers the FDA's specific concern with proof, not promises. It should be signed and dated, and it should address each violation point directly.

Contact Us →

The FDA wants evidence. It does not want explanations. If the detention cites a labeling problem, send corrected labels. If it cites a missing registration, send the registration confirmation.

A good response letter includes:

  • The detention or Notice of Action reference number
  • A point-by-point reply to each cited violation
  • Supporting documentation for every claim
  • A signed and dated cover letter from the importer of record

Step-by-Step Evidence Checklist

Use this checklist before you send anything to the FDA:

  • Detention notice reference number confirmed
  • Each violation point listed and answered
  • Corrected labels or product photos attached
  • Facility registration and product listing proof included

Missing even one item can trigger a second request, which adds days to the hold.

Pro Tip Send your response as a single complete package, not in pieces. Partial submissions restart the FDA's review clock, and that is where shipments quietly turn into losses.

The FDA Import Refusal Process and What Happens Next

The FDA import refusal process begins when the FDA decides the goods cannot be admitted. At that point, the shipment cannot enter U.S. commerce. The importer must re-export or destroy the goods within a set window.

Refusal is not always the end. Importers can:

  • Submit additional evidence for reconsideration
  • Request an opportunity to present evidence or a hearing in some cases
  • Re-export the goods to another market
  • Destroy the goods under FDA supervision

Each option carries cost. Re-export means paying freight twice. Destruction means losing the product value entirely.

Appeals, Hearings, and Escalation Options

An importer who believes the FDA's basis for detention or refusal is wrong has options beyond simply accepting the outcome. The FDA provides an opportunity to present evidence and, in some circumstances, to request a hearing. The practical path usually looks like this:

  1. Reconsideration request, Submit a written request to the FDA district office that issued the notice, with new or corrected evidence addressing the specific violation. This is the fastest and most common escalation.
  2. Informal hearing or meeting, For disputed findings, an importer may request an opportunity to present its case directly. The FDA decides whether to grant it.
  3. Formal appeal, In limited situations, an importer can seek review at a higher level within the agency. This is slower and typically reserved for significant disputes.
  4. Legal counsel, For high-value shipments or repeat detentions, engaging an attorney experienced in FDA import law is often the most efficient path. Counsel can also evaluate whether the agency's action exceeded its authority.

A common pattern is that importers who escalate without new evidence, simply restating their original position, rarely succeed. The FDA responds to proof, not argument.

Re-Export and Destruction: Mechanics and Costs

If refusal stands, the importer must choose between re-export and destruction. Re-export requires arranging outbound freight, often to a market that will accept the goods, and notifying the FDA of the export.

Neither option recovers the original product value. The goal at this stage is to limit the total loss, avoiding indefinite storage charges and closing out the entry so the importer can move on.

How Refusal Differs from Detention

Detention is a hold. Refusal is a decision. During detention, the importer still has a chance to prove admissibility. After refusal, the goods are barred from entry unless the importer successfully contests the decision or the FDA reconsiders.

The FDA documents its authority over imports in the Federal Food, Drug, and Cosmetic Act, which is the legal basis for detention and refusal.

Watch Out Do not let a refusal sit. The window to re-export or destroy is short, and storage charges continue to accrue. Importers who delay often find that the cost of holding the goods exceeds the cost of resolving them.

FDA Import Alert Removal: Getting Off the Red List

FDA import alert removal happens when a company proves its products consistently meet U.S. standards.

Getting off the list takes time and evidence. The FDA wants to see a track record.

The path usually involves:

  • Submitting evidence that the violation is fixed
  • Providing several clean shipments
  • Documenting corrective action
  • Requesting removal in writing

FDA Agent Pro helps foreign companies manage this process from start to finish.

The FDA outlines its import alert system on its Import Alerts page, where firms can check their status.

Conclusion: Protecting Your Company from Detention Liability

Detention liability is predictable once you know the rules. The importer of record carries the legal and financial weight.

That gap between who makes the product and who answers for it is where most companies get caught.

At FDA Agent Pro, we close that gap. We manage facility registrations, product listings, and labeling reviews for food, drug, device, and cosmetic exporters.

Contact Us to protect your shipments and your bottom line.

Frequently Asked Questions

Who is liable when the FDA detains an imported product?

The importer of record holds primary legal and financial responsibility for a detained shipment. This includes storage fees, reconditioning costs, and potential destruction expenses. While the foreign manufacturer may face contractual liability under their supply agreement, the FDA holds the importer of record accountable for regulatory compliance. If you use an FDA agent, they handle communications but do not assume liability. Always clarify liability terms in your purchase contracts before shipping.

What is the difference between an FDA import detention and an import alert?

An import detention applies to a specific shipment that FDA has flagged for examination or holds at the port. An import alert is a broader enforcement tool that allows FDA to detain products from a specific manufacturer or country without physical examination, known as DWPE. A detention is shipment-specific; an import alert affects future shipments. If your product is on an import alert, each new shipment may be detained automatically until you achieve FDA import alert removal.

How long can the FDA detain an imported product?

FDA has 5 working days after sampling to make an admissibility decision. If no decision is made within that window, the shipment is considered refused. However, the full FDA import detention timeline can stretch to 30 days or more if you submit a response letter and FDA needs time to review evidence. Storage costs accrue daily, so respond quickly with a complete FDA detention notice response letter to minimize delays.

Can an importer challenge an FDA detention?

Yes. You can submit a response letter with supporting documentation to overcome detention. If FDA refuses admission, you may request a hearing within 10 days or file an appeal. For import alert removal, you must provide evidence of corrective actions and may need to show consistent compliance. Working with an experienced FDA agent helps ensure your challenge meets regulatory procedures and avoids common mistakes that lead to seizure or destruction.